Search

everythinglearnresearchcommunity

for

Search:↓

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Cathepsin L is essential for normal hair growth and development.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

Wnt signaling may be linked to heart diseases in aging and could be a target for future treatments.

Two-photon microscopy helps observe hair follicle stem cell behaviors in mice.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

The protein SLC1A3 is important for activating skin stem cells and is necessary for normal hair and skin growth in mice.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive stomach cancer.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

Cetuximab can cause unusual hair growth and hair loss.

Special cell particles from macrophages can help hair grow.

Keratin proteins are essential for keeping the cells in the human colon healthy and stable.

Genetic changes in mice help understand skin and hair disorders, aiding treatment development for acne and hair loss.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.